1. Chuchalin AG, Vizel AA, Ilkovich MM, et al. Diagnosis and treatment of sarcoidosis: Summary of federal conciliative clinical recommendations. Bulletin of modern clinical medicine 2014; 7(4): 62-81. (Чучалин А. Г., Визель А. А., Илькович М . М . и др. Диагностика и лечение саркоидоза: Резюме Федеральных согласительные клинические рекомендаций. Вестник современной клинической медицины 2014; 7(4): 62-81).
2. Sekhri V, Sanal S, Delorenzo LJ, et al. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011; 7(4): 546-54.
3. Bagwan IN, Hooper LV, Sheppard MN. Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies. Virchows Arch. 2011; 458(6): 671-8.
4. Chapelon-Abric C. Cardiac sarcoidosis. Curr Opin Pulm Med. 2013; 19(5): 493-502.
5. Lam CS, Tolep KA, Metke MP, et al. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol. 2009; 32(6): E68-71.
6. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004; 83 (6): 315-34.
7. Viles-Gonzalez JF, Pastori L, Fischer A, et al. Supraventricular arrhythmias in patients with ardiac sarcoidosis prevalence, predictors, and clinical implications. Chest. 2013; 143(4): 1085-90.
8. Smedena JP. Tissue Doppler imaging in cardiac sarcoidosis. Eur J Echocardiol 2008; 9(4): 579-80.
9. Youssef G, Leung E, Mylonas I, et al. The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience. J Nucl Med 2012; 53(2): 241-8.
10. Dubrey SW, Falk RH. Diagnosis and Management of Cardiac Sarcoidosis. Progress in Cardiovascular Diseases 2010; 52 (4): 336-46.
11. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18Ffluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008; 35(5): 933-41.
12. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005; 184(1): 249–254.
13. Kouranos V, Tzelepis GE, Rapti A, et al. Utility of cardiac MRI in detecting myocardial involvement and predicting adverse events in sarcoidosis: A study in 330 patients. Eur Heart J 2015; 36 (Abstract Supplement): 543-4.
14. Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270 (5): 461-8.
15. Isobe M, Tezuka D. Isolated cardiac sarcoidosis: Clinical characteristics, diagnosis and treatment International Journal of Cardiology 2015; 182; 132-40.
16. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013 Jan 22; 61(3): e6-75.
17. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of suddencardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015 Aug 29. pii: ehv316.
18. Zipse MM, Sauer WH. Cardiac sarcoidosis and consequent arrhythmias. Card Electrophysiol Clin. 2015; 7(2): 235-49.
19. Rosenbaum AN, Edwards BS. Current indications, strategies, and outcomes with cardiac transplantation for cardiac amyloidosis andsarcoidosis. Curr Opin Organ Transplant. 2015; 20(5): 584-92.